Market Size
The Global Veterinary Diagnostics Market reached USD 8.82 billion in 2025 and is projected to witness lucrative growth by reaching up to USD 15.75 billion by 2033. The global veterinary diagnostic smarket is expected to exhibita CAGR of 8.7% during the forecast period (2026-2033).
Veterinary diagnostics are crucial for animal health, detecting health issues before they become serious and allowing for faster diagnosis and treatment planning. Traditional diagnosis is the examination of blood, tissue, urine, or faeces for the presence of proteins, antibodies, disease, or general markers of overall health. Digital diagnostics unleash the technology's preventative capacity by spotting trends in wellness data that human specialists may overlook, opening up new avenues for early disease diagnosis. Artificial intelligence and other cutting-edge approaches mean more potential to spot danger patterns in ever-increasing data volumes.
Additionally, the rise of veterinary diseases, growing number of pets adopted worldwide and other factors helps to grow the veterinary diagnostics market size. Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market is seeing an increase in demand from North American regions with significant key players like Ringbio, Virbac, PetDx, and others actively operating in the market.
Market Summary
| Metrics | Details |
| CAGR | 8.7% |
| Size Available for Years | 2025-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Product Type, Animal Type,Technology, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Largest Region | North America |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For More Insights about the Market Request Free Sample
Market Trends
Increasing Number of Pets Adopted Worldwide will Rise the Market Growth
The growing number of pets adopted worldwide fuels the global veterinary diagnostics market. For instance, according to ASPCA, approximately 6.3 million companion animals enter U.S. animal shelters nationwide every year. Of those, approximately 3.1 million are dogs and 3.4 million are cats. Approximately 4.1 million shelter animals are adopted each year (2 million dogs and 2.1 million cats).
Additionally, Pets, such as dogs and cats, are also known for offering companionship and emotional support. Especially during difficult times, such as the COVID-19 pandemic, when people were spending more time at home and feeling isolated, individuals craved the company of a pet. Numerous studies have demonstrated that engaging with pets can help people cope with stress, anxiety, and depression.
As individuals become more aware of the benefits of pets for mental health, more people sought out pets to boost their well-being. Pet adoption has increased due to the popularity of pet-focused material on social media platforms. People were more interested in owning pets after seeing adorable and comforting pet videos and photographs. Thus above factors helps to drive the market growth.
The Rising Prevalence of Pet Animal Diseases
Globally, the rising prevalence of pet animal illnesses and their transmission to humans supported market expansion. The rising prevalence of zoonotic illnesses and their transmission to humans, increased pet adoptions and the number of veterinary healthcare professionals, and more research into veterinary disease diagnosis are driving market expansion.
For instance, according to a study published in the Faculty Reviews 2022, more than 63% of human infections have zoonotic origins, whereas the other 45% have either developed from non-zoonotic sources or co-evolved with humans. Several zoonotic-origin illnesses have recently resulted in an outbreak and have damaged the global human population. As a result, the rise of pet animal diseases contributes to market growth.
The Increasing Pet Care Costs and Shortage of Veterinarians
However, the increasing pet care costs and shortage of veterinarians are anticipated to hinder the growth of the veterinary diagnostics market. The U.S. Bureau Of Labor Statistics Occupational Employment and Wages, in May 2021, indicated that only 77,260 veterinarians are practicing for the 90.5 million U.S households with pets.
Also, the average cost of owning a pet can range from $700 to $1,100 per year, as per the type and size of pet, according to the American Society for the Prevention of Cruelty to Animals. Thus, it will slow the global veterinary diagnostics market growth in the forecast period.
Segment Analysis
The global veterinary diagnostics market is segmented based on product type, animal type, technology, application, end user and region.
The Analyzers Segment Accounted for Approximately 41.07% of the Veterinary DiagnosticsMarket Share
Veterinary diagnostics analyzers are extremely important in the field of veterinary medicine. These advanced tools are meant to perform numerous diagnostic tests and analyses on animal samples, assisting veterinarians in accurately diagnosing diseases and monitoring their patients' health state.
Additionally, the strategies followed by companies helps to boost the segment growth. For instance, on December 21, 2022, EKF Diagnostics, a global in vitro diagnostics firm, has announced the launch of a new version of their Lactate Scout analyzer, specifically tailored for use in veterinary settings. Lactate Scout Vet employs the same tried-and-true technology that was first created to equip professional sports coaches and athletes with a precise and user-friendly handheld lactate test.
Additionally, in Feburary 2023, VolitionRx Limited, an epigenetics firm, has announced that their Nu.Q Vet Cancer Test is currently available for pre-order through Heska Corporation to veterinarians at the point-of-care. Heska's Nu.Q Canine Cancer Screen and Monitor Test will be run using Heska's proprietary Element i+ Immunodiagnostic Analyzer, a point-of-care platform that gives veterinarians with on-site testing that is speedy, accurate, low cost, and simple to use. Thus, the aforementioned variables drive segment expansion.
Market Geographical Share
North America Accounted for Approximately 43.4% of the Market Share in 2022
Growing pet adoptions, increased expenditure on pet health, and product releases by companies all contribute to the region's success. For instance, in July 2022, PSIvet, the nation's largest veterinary group purchasing organisation, has announced an agreement with Bionote USA, a developer of quantitative, point-of-care veterinary analyzers and biomarker assays.
The collaboration will lower the cost of Bionote USA's Vcheck series of analyzers and tests for PSIvet's 5,000-plus veterinary practises. The Vcheck V200 analyzer and tests can be utilised as a supplement to a veterinary clinic's point-of-care lab for speedier diagnosis and treatment plan initiation, as well as significant cost savings per test.
Additionally, on April 19, 2022, Zoetis announced the inclusion of artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan ImagystTM, as its latest diagnostic breakthrough. Vetscan Imagyst, which will be available in September 2020, is a first-of-its-kind technology with a wide range of applications, including AI faecal analysis, digital cytology image transfer, and now AI blood smear - ultimately assisting veterinarians in broadening in-clinic diagnostic offerings to provide the best possible care for dogs and cats. Thus, the aforementioned reasons promote the region's growth.
Market Key Players
The major global players in the veterinary diagnostics market Zoetis, Thermo Fisher Scientific, Covetrus, Inc, PetDx, HORIBA UK Limited, Ringbio, Virbac, IDVet, Abaxis, Heska Corporation and others.
Key Developments
- On April 18, 2026, global veterinary healthcare initiatives emphasized the rapid adoption of AI-enabled and molecular diagnostic platforms across companion animal and livestock healthcare. Increasing focus on zoonotic disease surveillance, preventive care, and rapid in-clinic testing accelerated investments in veterinary diagnostics infrastructure worldwide.
- On March 8, 2026, IDEXX Laboratories expanded its advanced veterinary diagnostic portfolio with increased deployment of next-generation in-clinic analyzers and cancer screening solutions for companion animals. The expansion supports faster disease detection, improved workflow efficiency, and growing demand for preventive veterinary healthcare services.
- On February 2026, BioVenic expanded its veterinary molecular diagnostic development services, strengthening support for research teams developing next-generation animal disease testing platforms. The initiative aims to accelerate commercialization of precise molecular diagnostic tools for infectious and chronic veterinary diseases.
- On January 2026, veterinary industry reports highlighted strong growth in the global veterinary diagnostics market driven by rising pet ownership, increasing livestock disease monitoring, expanding use of point-of-care diagnostics, and growing adoption of advanced molecular and AI-based testing technologies.
- On December 2025, the ICAR-Indian Veterinary Research Institute organized an advanced training program focused on serological and molecular diagnostic techniques for livestock and poultry diseases. The initiative supported wider adoption of modern veterinary diagnostic technologies across emerging markets.
- On November 2025, veterinary diagnostic companies increased investments in rapid infectious disease testing solutions amid rising concerns over transboundary livestock diseases and zoonotic infections. Expanding disease surveillance programs strengthened demand for high-throughput diagnostic systems globally.
- On September 2025, Zomedica strengthened its veterinary diagnostics intellectual property portfolio with multiple newly issued patents covering its TRUVIEW digital cytology and TRUFORMA diagnostic platforms. The development reinforced innovation in automated veterinary diagnostic technologies and in-clinic testing systems.
- On June 2025, bioMérieux launched VETFIRE™, a rapid PCR veterinary diagnostic test capable of detecting multiple equine respiratory pathogens within minutes. The launch strengthened rapid molecular diagnostics adoption and supported improved antimicrobial stewardship in veterinary healthcare.
- On March 2025, Antech introduced trūRapid™ FOUR, a rapid in-house veterinary diagnostic screening test for canine vector-borne diseases including Lyme disease, Ehrlichia, Anaplasma, and heartworm. The product launch enhanced point-of-care diagnostic capabilities for veterinary clinics globally.
- On January 2025, IDEXX Laboratories launched IDEXX Cancer Dx, a low-cost blood test designed for early detection of canine lymphoma as part of routine wellness screening programs. The innovation strengthened the growing role of oncology diagnostics in companion animal healthcare.
Why Purchase the Report?
- To visualize the global veterinary diagnostics market segmentation based on product type, animal type, technology, application, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of veterinary diagnostics market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global veterinary diagnostics market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
